. . . . . . . . . . . . . "p(HGNC:NFE2L2) -> path(SDIS:\"Cisplatin resistance\")" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "Although the cell viability decreased dose-dependently in all cell lines by treatment with CDDP, A549 cells were more resistant to CDDP compared with LCAI and NCI-H292 cells (Fig. 2B). Nrf2 knockdown with Nrf2- siRNA significantly enhanced the susceptibility to CDDP in A549 cells (Fig. 2B)." . . "Selventa" . . . . "2014-07-03T14:33:34.705+02:00"^^ . . .